Table 4.
Variable | Anxiety state | χ2 | Cramer’s V | P- value | |
---|---|---|---|---|---|
Yes | No | ||||
(n = 60) | (n = 220) | ||||
Gender | 2.441 | 0.095 | 0.118 | ||
Male | 14 | 71 | |||
Female | 46 | 138 | |||
Aerosolization proceduresa | 0.009 | 0.006 | 0.926 | ||
Yes | 44 | 152 | |||
No | 16 | 57 | |||
Conflicts with colleagues and/or patientsb | 13.833 | 0.227 | < 0.001 | ||
Yes | 14 | 14 | |||
No | 46 | 195 | |||
Treatment on suspected or confirmed casesc | 5.200 | 0.139 | 0.023 | ||
Yes | 11 | 17 | |||
No | 49 | 192 | |||
Exposure to potential infectious substance d | 3.252 | 0.110 | 0.071 | ||
Yes | 18 | 40 | |||
No | 42 | 169 | |||
PM-3e | 10.246 | 0.195 | 0.001 | ||
Yes | 43 | 185 | |||
No | 17 | 24 |
aDid you often perform aerosolization procedures?
bDid you have conflicts with colleagues and/or patients in the last 6 months?
cHave you performed treatment on suspected or confirmed cases of COVID-19?
dHave your skin or wounds been exposed to the blood, saliva, or other body fluids of patients?
eDoes your workplace follow PM-3 guideline?